UK Clinical Trials Gateway

UK Clinical Trials Gateway
Name	UK Clinical Trials Gateway
Type	Information service
Founded	2011
Location	United Kingdom
Parent organisation	National Institute for Health Research

UK Clinical Trials Gateway The UK Clinical Trials Gateway was a public-facing information service that listed clinical trials recruiting participants across the United Kingdom. It aimed to connect patients, carers and health professionals with research studies and to increase public awareness of clinical research in the NHS, the National Institute for Health Research, and allied research bodies. The service aggregated trial metadata from multiple registries and supported transparency initiatives associated with biomedical research, evidence synthesis and regulatory frameworks.

Overview

The Gateway provided searchable summaries of interventional studies, diagnostic trials and observational studies sponsored or hosted by NHS trusts, universities and pharmaceutical companies. Entries described trial objectives, eligibility criteria, locations and contact details to facilitate recruitment through trust trial offices and coordinating centres such as the Clinical Research Network and academic health science centres. The platform operated alongside registries like ClinicalTrials.gov, the European Clinical Trials Database, and ISRCTN to improve discoverability for patients engaged with charities, patient advocacy groups and specialist centres. Stakeholders included trial sponsors, research ethics committees, university departments and commissioning bodies within the health research ecosystem.

History and Development

The service was developed in the context of policy reforms and research transparency movements that followed high-profile trials and regulatory milestones. Its inception reflected initiatives from the Department of Health, parliamentary inquiries and advisory bodies that sought to modernize research infrastructure and respond to challenges highlighted by litigation, high-profile drug approvals and major public health events. Development involved collaboration among the National Institute for Health Research, UK Clinical Research Collaboration, academic consortia and industry partners. Over time the Gateway integrated feeds from registries created in response to international agreements such as the International Committee of Medical Journal Editors policies, the European Union Clinical Trials Regulation, and the World Health Organization trial registration dataset to harmonize metadata presentation.

Purpose and Services

The primary purpose was to facilitate patient recruitment and public engagement by providing lay summaries and contact pathways for trials run by NHS trusts, university research groups, and contract research organisations. Services included search filters by condition, intervention, location and sponsor; referral links to site trial teams; resources for participants about informed consent and trial phases; and signposting to disease-specific organisations, specialist centres and national screening programmes. The platform supported linkage with electronic health record initiatives, clinical research networks and hospital research offices to streamline referral and eligibility checks for studies in areas such as oncology, cardiology, neurology and rare diseases.

Governance and Funding

Governance arrangements involved oversight by research funders, advisory panels with academic representation, and patient and public involvement panels drawn from charities, patient networks and volunteer cohorts. Funding streams combined central allocations from the National Institute for Health Research, contributions from partner medical schools, and programme support from research councils and charitable foundations. Accountability mechanisms referenced guidance from regulatory bodies, ethics committees, and audit practices used by trusts, university hospitals, and international partners engaged in multicentre trials.

Registration and Data Sources

The Gateway collated records from established registries and sponsor submissions, mapping fields from sources such as ClinicalTrials.gov, the European Clinical Trials Register, the ISRCTN Registry, the WHO International Clinical Trials Registry Platform, and sponsor databases maintained by pharmaceutical companies and university trial units. Data curation processes reconciled trial identifiers, recruitment status, sponsor attribution and site lists supplied by NHS trusts, academic departments and contract research organisations. Metadata alignment supported cross-referencing with trial results posted by sponsors, journal publications indexed by major bibliographic databases, and trial summaries required by regulatory authorities overseeing approvals and safety monitoring.

Impact and Usage

By centralising discoverability, the Gateway contributed to recruitment efforts for multicentre studies, vaccine trials, and investigator-led trials at university teaching hospitals and specialist centres. Patient groups, clinical networks and charity partners used the service to raise awareness of trials in oncology, cardiology, infectious diseases and rare conditions, helping investigators meet enrolment targets and enabling systematic reviewers and health technology assessment bodies to identify ongoing studies. Evaluations referenced recruitment metrics, partnership case studies with academic health science centres, and anecdotal reports from trial coordinators and patient organisations indicating improved public access to trial information.

Criticism and Challenges

Critiques centred on data completeness, latency of updates from registries, and inconsistencies between lay summaries and protocol documents maintained by sponsors and university trial units. Challenges included harmonising data standards across ClinicalTrials.gov, the European Clinical Trials Database and ISRCTN, ensuring up-to-date recruitment status at NHS sites, and meeting expectations from patient advocates about comprehensiveness for rare disease portfolios. Technical and resourcing constraints affected integration with electronic health record initiatives and automated eligibility matching; governance debates addressed responsibilities among funders, host institutions and industry sponsors for maintaining accuracy and transparency.

Category:Clinical trials Category:Medical research in the United Kingdom Category:National Institute for Health Research